Email: cspc@cspc.cn
Media
News Center
Jun. 03
2024
VOLUNTARY ANNOUNCEMENT OLAPARIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL
May. 17
VOLUNTARY ANNOUNCEMENT RECOMBINANT FULLY HUMAN ANTI-βKlotho MONOCLONAL ANTIBODY DRUG (JMT202) OBTAINS CLINICAL TRIAL APPROVAL
May. 14
VOLUNTARY ANNOUNCEMENT PERAMIVIR INJECTION OBTAINS DRUG REGISTRATION APPROVAL
May. 13
CSPC Re-selected into TOP 25 Global Pharmaceutical Companies by Pipeline Size
May. 02
CSPC Subsidiary Wins Provincial May Day Labor Award
May. 01
CSPC Shijiazhuang Research Institute Awarded National Workers Pioneer
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
